Ben Fidler will be returning back to the biotech world as he joins the team at BioPharma Dive as a senior editor.
Previously, he was a deputy editor biotech at Xconomy where he managed a team of biotech writers for a digital media and events company, reporting directly to the editor-in-chief.
He also covered the global biotech and pharmaceutical industry, focusing on breaking news and unique angles.
He also served as a senior reporter, bankruptcy and restructuring and senior reporter, health care at The Deal LLC. There, he covered multi-billion-dollar M&A transactions, venture financings, high-profile restructurings and much more.
Fidler received his bachelor’s degree in English and journalism from Binghamton University.
The Star Tribune is seeking an accomplished, motivated and versatile journalist and leader to shape…
The Deputy AME-Business is responsible for the development and planning of coverage on all Newsday…
CNBC.com managing editor Jeff McCracken announced Friday the following promotions: In San Francisco, Ari Levy has…
This Newsday reporter will cover Long Island’s commercial real estate market and the region’s evolving…
The New York Times is looking for a versatile editor to edit enterprise and feature…
International editor Matt Lamers is leaving Marijuana Business Daily. He has been there for seven years. Lamers…